Michael Fox, MD, PhD, is the Founding Director of the Center for Brain Circuit Therapeutics and an Associate Professor of Neurology at Harvard Medical School. Dr. Fox’s goal is to use research advances in brain imaging and neuromodulation technology to provide better treatments for his patients, especially patients with symptoms that are refractory to medication.  He approaches both neurological and psychiatric symptoms as disorders of brain circuits, and uses tools such as deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), and focused ultrasound (FUS) to target these circuits for symptom relief. 

Dr. Fox’s clinical practice focuses on patients with medication-refractory neurological or psychiatric symptom that may benefit from neuromodulation therapy.  His practice includes deep brain stimulation (DBS) for the treatment of Parkinson's Disease, essential tremor, and dystonia, focused ultrasound (FUS) for the treatment of tremor, and transcranial magnetic stimulation (TMS) for the treatment of medication-refractory depression.  

Dr Fox’s research focuses on developing new and improved treatments for brain disease based on understanding brain circuits and the effects of brain stimulation. He helped develop brain imaging techniques for visualizing human brain circuits, and is a leader in applying these techniques towards improved neuromodulation therapies. He is the author of numerous highly cited articles in the fields of brain imaging and brain stimulation, teaches courses on these topics, and has won many awards for his work.